The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients
Abstract
The Fifth European Conference on Infections in Leukaemia (ECIL-5) convened a meeting to establish evidence-based recommendations for using tests to diagnose Pneumocystis jirovecii pneumonia (PCP) in adult patients with haematological malignancies. Immunofluorescence assays are recommended as the most sensitive microscopic method (recommendation A-II). Real-time PCR is recommended for the routine diagnosis of PCP (A-II). Bronchoalveolar lavage (BAL) fluid is recommended as the best specimen as it yields good negative predictive value (A-II). Non-invasive specimens can be suitable alternatives (B-II), acknowledging that PCP cannot be ruled out in case of a negative PCR result (A-II). Detecting β-d-glucan in serum can contribute to the diagnosis but not the follow-up of PCP (A-II). A negative serum β-d-glucan result can exclude PCP in a patient at risk (A-II), whereas a positive test result may indicate other fungal infections. Genotyping using multilocus sequence markers can be used to investigate suspected outbreaks (A-II). The routine detection of dihydropteroate synthase mutations in cases of treatment failure is not recommended (B-II) since these mutations do not affect response to high-dose co-trimoxazole. The clinical utility of these diagnostic tests for the early management of PCP should be further assessed in prospective, randomized interventional studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303
Successful Chemoprophylaxis for Pneumocystis carinii Pneumonitis
Hughes, W. T., Kuhn, S., Chaudhary, S., Feldman, S., Verzosa, M., Aur, R. J. A., Pratt, C., & George, S. L. (1977) · New England Journal of Medicine · doi:10.1056/nejm197712292972602 · Cited by 690
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients
Stern, A., Green, H., Paul, M., Vidal, L., & Leibovici, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005590.pub3 · Cited by 452
Detection of Pneumocystis carinii with DNA amplification
Wakefield, A. E., Pixley, F. J., Banerji, S., Sinclair, K., Moxon, E. R., Miller, R. F., & Hopkin, J. M. (1990) · The Lancet · doi:10.1016/0140-6736(90)92008-6 · Cited by 403
Successful Intermittent Chemoprophylaxis for Pneumocystis carinii Pneumonitis
Hughes, W. T., Rivera, G. K., Schell, M. J., Thornton, D., & Lott, L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162604 · Cited by 398
[Detection of Pneumocystis carinii with DNA amplification].
Kitada, K., & Nakamura, Y. (1992) · PubMed · Cited by 394
Green, H., Paul, M., Vidal, L., & Leibovici, L. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.9.1052 · Cited by 379
Skiada, A., Lanternier, F., Groll, A. H., Pagano, L., Zimmerli, S., Herbrecht, R., Lortholary, O., Petrikkos, G. L., & Leukemia*, O. B. O. T. T. E. C. O. I. I. (2013) · Haematologica · doi:10.3324/haematol.2012.065110 · Cited by 372
Onishi, A., Sugiyama, D., Kogata, Y., Saegusa, J., Sugimoto, T., Kawano, S., Morinobu, A., Nishimura, K., & Kumagai, S. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.05267-11 · Cited by 328
Lamoth, F., Cruciani, M., Mengoli, C., Castagnola, E., Lortholary, O., Richardson, M., Marchetti, O., & (ECIL-3), O. B. O. T. T. E. C. O. I. I. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir897 · Cited by 302
Cited by
Diagnosis of invasive fungal infections: challenges and recent developments
Fang, W., Wu, J., Cheng, M., Zhu, X., Du, M., Chen, C., Liao, W., Zhi, K., & Pan, W. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00926-2 · Cited by 356
Maertens, J. A., Girmenia, C., Brüggemann, R. J., Duarte, R. F., Kibbler, C. C., Ljungman, P., Racil, Z., Ribaud, P., Slavin, M. A., Cornely, O. A., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky286 · Cited by 348
Self-citationDiagnosis of severe respiratory infections in immunocompromised patients
Azoulay, E., Russell, L., Van de Louw, A., Metaxa, V., Bauer, P., Povoa, P., Montero, J. G., Loeches, I. M., Mehta, S., Puxty, K., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05906-5 · Cited by 346
Fishman, J. A., Gans, H., & Practice, T. A. I. D. C. O. (2019) · Clinical Transplantation · doi:10.1111/ctr.13587 · Cited by 293
Acute graft-versus-host disease
Malard, F., Holler, E., Sandmaier, B. M., Huang, H., & Mohty, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00438-1 · Cited by 268
Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients
Giacobbe, D. R., Del Bono, V., Viscoli, C., & Mikulska, M. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1401467 · Cited by 27
Hammarström, H., Stjärne Aspelund, A., Christensson, B., Heußel, C. P., Isaksson, J., Kondori, N., Larsson, L., Markowicz, P., Richter, J., Wennerås, C., et al. (2018) · Mycoses · doi:10.1111/myc.12773 · Cited by 15
Metadata
- Authors
- Alanio, A., Hauser, P. M., Lagrou, K., Melchers, W. J. G., Helweg-Larsen, J., Matos, O., Cesaro, S., Maschmeyer, G., Einsele, H., Donnelly, J. P., Cordonnier, C., Maertens, J., & Bretagne, S.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-05-12
- Volume
- 71
- Issue
- 9
- Pages
- 2386-2396
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2384346244
- Cited by
- 417
- References
- 104
- FWCI
- 35.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.